Takeda Pharmaceutical Company Limited
US ˙ OTCPK ˙ JP3463000004

SecurityTKPHF / Takeda Pharmaceutical Company Limited
InstitutionPacer Advisors, Inc.
Latest Disclosed Ownership2,359,239 shares
Latest Disclosed Value $ 91,201,694
Pacer Advisors, Inc. reports 23.53% increase in ownership of TKPHF / Takeda Pharmaceutical Company Limited

On May 6, 2026 - Pacer Advisors, Inc. filed a 13F-HR form disclosing ownership of 2,359,239 shares of Takeda Pharmaceutical Company Limited (US:TKPHF) valued at $91,201,694 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 24, 2026 disclosing 1,909,880 shares of Takeda Pharmaceutical Company Limited. This represents a change in shares of 23.53% during the quarter. The current value of the position is $63,369,160 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F Par Pacific Holdings Common Stock - Domestic 006870445 2,359,239 449,359 23.53 91,202 54.70 0.2351
2026-02-24 2025-12-31 13F/A-1 Takeda Pharmaceutical Common Stock - Foreign 006870445 1,909,880 1,091,904 133.49 58,952 147.01 0.1506
2026-02-04 2025-12-31 13F Pinterest Common Stock - Domestic 006870445 4,861,301 4,043,325 135,364 0.1849
2025-10-15 2025-09-30 13F Takeda Pharmaceutical Common Stock - Foreign 006870445 817,976 19,429 2.43 23,867 -2.73 0.0601
2025-08-12 2025-06-30 13F Takeda Pharmaceutical Common Stock - Foreign 006870445 798,547 -49,205 -5.80 24,538 -1.62 0.0610
2025-05-06 2025-03-31 13F Takeda Pharmaceutical Common Stock - Foreign 006870445 847,752 24,730 3.00 24,943 14.05 0.0584
2025-01-22 2024-12-31 13F Takeda Pharmaceutical Common Stock - Foreign 006870445 823,022 822,810 388,117.92 21,869 364,383.33 0.0472
2024-11-12 2024-09-30 13F Takeda Pharmaceutical Common Stock - Foreign 006870445 212 212 6 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.